BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26468283)

  • 1. Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.
    Haapasalo K; van Kessel K; Nissilä E; Metso J; Johansson T; Miettinen S; Varjosalo M; Kirveskari J; Kuusela P; Chroni A; Jauhiainen M; van Strijp J; Jokiranta TS
    J Biol Chem; 2015 Nov; 290(48):28977-87. PubMed ID: 26468283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbes bind complement inhibitor factor H via a common site.
    Meri T; Amdahl H; Lehtinen MJ; Hyvärinen S; McDowell JV; Bhattacharjee A; Meri S; Marconi R; Goldman A; Jokiranta TS
    PLoS Pathog; 2013; 9(4):e1003308. PubMed ID: 23637600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.
    Nissilä E; Hakala P; Leskinen K; Roig A; Syed S; Van Kessel KPM; Metso J; De Haas CJC; Saavalainen P; Meri S; Chroni A; Van Strijp JAG; Öörni K; Jauhiainen M; Jokiranta TS; Haapasalo K
    Front Immunol; 2018; 9():2701. PubMed ID: 30519244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
    Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
    J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking Factor H for Complement Immune Evasion.
    Moore SR; Menon SS; Cortes C; Ferreira VP
    Front Immunol; 2021; 12():602277. PubMed ID: 33717083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.
    Duthy TG; Ormsby RJ; Giannakis E; Ogunniyi AD; Stroeher UH; Paton JC; Gordon DL
    Infect Immun; 2002 Oct; 70(10):5604-11. PubMed ID: 12228288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II.
    Hannuksela ML; Brousseau ME; Meyn SM; Nazih H; Bader G; Shamburek RD; Alaupovic P; Brewer HB
    Atherosclerosis; 2002 Dec; 165(2):205-20. PubMed ID: 12417271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
    Hyvärinen S; Meri S; Jokiranta TS
    Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
    Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
    J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Scl1 protein of M6-type group A Streptococcus binds the human complement regulatory protein, factor H, and inhibits the alternative pathway of complement.
    Caswell CC; Han R; Hovis KM; Ciborowski P; Keene DR; Marconi RT; Lukomski S
    Mol Microbiol; 2008 Feb; 67(3):584-96. PubMed ID: 18093091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver.
    Marmillot P; Rao MN; Liu QH; Lakshman MR
    Metabolism; 1999 Sep; 48(9):1184-92. PubMed ID: 10484062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional characterization of the product of disease-related factor H gene conversion.
    Herbert AP; Kavanagh D; Johansson C; Morgan HP; Blaum BS; Hannan JP; Barlow PN; Uhrín D
    Biochemistry; 2012 Mar; 51(9):1874-84. PubMed ID: 22320225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.
    Jokiranta TS; Cheng ZZ; Seeberger H; Jòzsi M; Heinen S; Noris M; Remuzzi G; Ormsby R; Gordon DL; Meri S; Hellwage J; Zipfel PF
    Am J Pathol; 2005 Oct; 167(4):1173-81. PubMed ID: 16192651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple ligand binding sites on domain seven of human complement factor H.
    Giannakis E; Male DA; Ormsby RJ; Mold C; Jokiranta TS; Ranganathan S; Gordon DL
    Int Immunopharmacol; 2001 Mar; 1(3):433-43. PubMed ID: 11367528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6.
    Bechtler C; Koutsogiannaki S; Umnyakova E; Hamid A; Gautam A; Sarigiannis Y; Pouw RB; Lamers C; Rabbani S; Schmidt CQ; Lambris JD; Ricklin D
    Acta Biomater; 2023 Jan; 155():123-138. PubMed ID: 36328123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
    Kajander T; Lehtinen MJ; Hyvärinen S; Bhattacharjee A; Leung E; Isenman DE; Meri S; Goldman A; Jokiranta TS
    Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2897-902. PubMed ID: 21285368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation.
    Hubin E; Verghese PB; van Nuland N; Broersen K
    FEBS Lett; 2019 Jun; 593(11):1144-1153. PubMed ID: 31058310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H.
    Hebecker M; Alba-Domínguez M; Roumenina LT; Reuter S; Hyvärinen S; Dragon-Durey MA; Jokiranta TS; Sánchez-Corral P; Józsi M
    J Immunol; 2013 Jul; 191(2):912-21. PubMed ID: 23772024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.